{"title":"MHRA 发布两份氟喹诺酮类药物安全性的最新报告","authors":"BMJ Publishing Group Ltd","doi":"10.1136/dtb.2023.000069","DOIUrl":null,"url":null,"abstract":"### Key learning points The Medicines and Healthcare products Regulatory Agency has issued two updates about serious safety issues associated with systemic fluoroquinolone antibiotics.1 2 In 2019, restrictions on the use of fluoroquinolone antibiotics were introduced because …","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MHRA issues two updates on fluoroquinolone safety\",\"authors\":\"BMJ Publishing Group Ltd\",\"doi\":\"10.1136/dtb.2023.000069\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"### Key learning points The Medicines and Healthcare products Regulatory Agency has issued two updates about serious safety issues associated with systemic fluoroquinolone antibiotics.1 2 In 2019, restrictions on the use of fluoroquinolone antibiotics were introduced because …\",\"PeriodicalId\":11277,\"journal\":{\"name\":\"Drug and Therapeutics Bulletin\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and Therapeutics Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/dtb.2023.000069\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Therapeutics Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/dtb.2023.000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
### Key learning points The Medicines and Healthcare products Regulatory Agency has issued two updates about serious safety issues associated with systemic fluoroquinolone antibiotics.1 2 In 2019, restrictions on the use of fluoroquinolone antibiotics were introduced because …
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
